mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
0.23 |
0.5 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.5 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.5 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |